Bispecific antibodies for targeted cellular cytotoxicity.
Bispecific antibodies have the ability to redirect normal cytotoxic mechanisms to kill tumors or pathogens and thus represent a potentially powerful tool for the therapy of cancer and infectious disease.
Fanger
M W
MW
Department of Microbiology, Dartmouth Medical School, Hanover, NH.
Guyre
P M
PM
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology* / Q000627:therapeutic use; D000918:Antibody Specificity; D000920:Antibody-Dependent Cell Cytotoxicity / Q000276:immunology*; D006801:Humans
D000911:Antibodies, Monoclonal